APP and cerebral creatine deficiency syndrome: We identified a significantly lower expression of RBP4, CXCL10, and NOX4 in the plasma of CCDS canines than in normal canines, consistent with the results obtained from APP/PS1 and MPTP-induced mice (Figure 2B).